Antibody Targeted Natural Killer Cell-Derived Extracellular Vesicles for the Treatment of Childhood Acute Lymphoblastic Leukemia and Neuroblastoma |
Children’s Hospital Los Angeles / Robert Seeger, MD & Alan Wayne, MD |
Innovation Grants |
2015 |
California |
Immunotherapeutic Targeting of Stem Cells in Pediatric Brain Tumors
|
Harbor - UCLA Medical Center / Joseph Lasky |
Young Investigator Grants |
2008 |
California |
Identifying Novel Therapeutic Combinations with 131I-MIBG to Treat Relapsed and Refractory Neuroblastoma |
The Regents of the University of California San Francisco / William Clay Gustafson, M.D., Ph.D. |
Reach Grants |
2014 |
California |
Neuronal Damage, Neurocognitive Losses and Quality of Life Following High-Dose Chemotherapy in Children with Brain Tumors |
Children’s Hospital Los Angeles / Mary Nelson |
Nurse Researcher Grants |
2009 |
California |
Synergistic Activity of Anti-GD2 Antibody and CD47-Blockade for Immunotherapy of Neuroblastoma and Osteosarcoma |
The Board of Trustees of the Leland Stanford Junior University / Robbie Majzner, MD |
'A' Award Grants |
2019 |
California |
A Pilot Study of the Feasibility and Acceptability of an Interactive Computerized Symptom Assessment Tool to Assess Disease and Treatment-Related Symptoms Experienced by Children with Cancer |
University of California San Francisco / Tina Baggott, RN, PhD, PNP |
Nurse Researcher Grants |
2009 |
California |
Endocrine Disrupting Pesticides, Neonatal Hormones and Risk of Testicular Germ Cell Tumors |
University of California Berkeley / Catherine Metayer, MD, PhD |
Epidemiology Grants |
2018 |
California |
Role of Fetal Growth in Pediatric Rhabdomyosarcoma |
University of California Berkeley / Catherine Metayer, MD, PhD |
Epidemiology Grants |
2013 |
California |
Predicting Outcome for Patients with Metastatic Neuroblastoma by Analysis of Bone Marrow and Blood for a Neuroblastoma Gene Expression Signature |
Children’s Hospital Los Angeles / Robert Seeger |
Innovation Grants |
2010 |
California |
Single Cell Analysis of Leukemia Initiation |
Stanford University / Michael Cleary, MD |
Innovation Grants |
2015 |
California |